Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about XNAS:SNGX
Recent news which mentions XNAS:SNGX
Soligenix Issues Interim Results For CTCL Treatment Trial 75% Response At 18 Weeks, 3 Patients Achieve Complete Response
May 05, 2025
Tickers
SNGX
Tags
en/US
Benzinga
XNAS:SNGX
From
TheNewswire.com - RSS (Media)
Soligenix's HyBryte(TM) Shows 75% Response Rate In Skin Cancer Trial, Backed By FDA Funding
April 24, 2025
Tickers
SNGX
TM
Tags
en/US
XNAS:SNGX
Benzinga
From
TheNewswire.com - RSS (Media)
Soligenix Aims To Push The Boundaries In Treating Rare Diseases
February 25, 2025
Tickers
SNGX
Tags
XNAS:SNGX
Benzinga
en/US
From
TheNewswire.com - RSS (Media)
Improving Patient Quality Of Life: Soligenix Progresses Treatment For Painful Ulcers Associated With Rare Behcet's Disease
February 21, 2025
Tickers
SNGX
Tags
en/US
XNAS:SNGX
Benzinga
From
TheNewswire.com - RSS (Media)
Soligenix's Leadership Aims To Drive Growth In Rare Disease Markets In 2025 And 2026
February 21, 2025
Tickers
SNGX
Tags
en/US
XNAS:SNGX
Benzinga
From
TheNewswire.com - RSS (Media)
Soligenix Announces Participation at the Spartan Capital Investor Conference
October 29, 2024
Tickers
SNGX
Tags
XNAS:SNGX
Soligenix, Inc/
From
TheNewswire.com - RSS (Media)
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.